2007 Award for Outstanding Scientific Achievements by a Young Investigator
Dr. Langman is director of the drug/toxicology laboratory at the Mayo Clinic in Rochester, Minn. She has produced more than 30 publications and 40 abstracts/presentations at national and international meetings. She has many areas of expertise in toxicology, particularly in antipsychotic drugs, drugs of abuse (particularly amphetamine-type stimulants), post-mortem toxicology, and pharmacogenetics. Her current research interests include pharmacogenomics of amphetamine-type stimulants, and genotype–phenotype relationships of psychoactive medications. She is the first individual to have achieved diplomate status in all three disciplines offered by the American Board of Clinical Chemistry: clinical chemistry, molecular diagnostics, and toxicological chemistry. Dr. Langman serves on committees for several professional organizations, including the AACC, Society of Forensic Toxicologists, American Academy of Forensic Sciences, National Academy of Clinical Biochemistry, Canadian Society of Clinical Chemists, International Association of Therapeutic Drug Monitoring and Clinical Toxicology, and New York Academy of Sciences.